Foci Pharmaceuticals: Announcement on providing guarantees for wholly-owned subsidiaries
Foci Pharmaceutical: Announcement of Resolutions of the Third Meeting of the Eighth Board of Directors
Foci Pharmaceuticals: 002644 Foci Pharmaceuticals Investor Relations Management Information 20240920
Foci Pharmaceutical: Continued supervision of Hualong Securities Co., Ltd. on Gansu State-owned Assets Investment Group Co., Ltd.\'s offer to acquire Lanzhou Foci Pharmaceutical Co., Ltd. in the second quarter of 2024
Foci Pharmaceuticals: 002644 Foci Pharmaceuticals Investor Relations Management Information 20240828
Foci Pharmaceuticals: 2024 Semi-Annual Financial Report
Foci Pharmaceuticals: Semi-Annual Report Board Resolution Announcement
Foci Pharmaceuticals: Semi-Annual Summary of Non-operating Capital Utilization and Other Related Capital Transactions
Buddha\'s Pharmaceutical: 2024 Semi-Annual Report Summary
Foci Pharmaceuticals: Announcement on increasing the forecast for daily related transactions in 2024
Buddha Tzu Pharmaceuticals: Semi-Annual Report 2024
Lanzhou Foci Pharmaceutical: Announcement of the resolution of the first meeting of the eighth board of supervisors.
Lanzhou Foci Pharmaceutical: Announcement of Resolutions Passed at the First Meeting of the Eighth Board of Directors.
Lanzhou Foci Pharmaceutical: Legal opinion of Gansu Jincheng Law Firm on the second interim shareholders' meeting of Lanzhou Foci Pharmaceutical Co., Ltd. in 2024.
Lanzhou Foci Pharmaceutical: Announcement regarding the completion of the board of directors and the supervisory board's election and appointment of senior management personnel.
Lanzhou Foci Pharmaceutical: Announcement Regarding the Election of Employee Representatives of the Eighth Supervisory Board
Lanzhou Foci Pharmaceutical: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Lanzhou Foci Pharmaceutical: Notice Regarding the Second Extraordinary Shareholder Meeting in 2024 (Updated)
Lanzhou Foci Pharmaceutical: Announcement on the Election of the Supervisory Board
Lanzhou Foci Pharmaceutical: Statement and Commitment of Independent Director Nominee (Hu Huayun)
No Data
No Data